Analyst Insights and Signify Premium Insights

In recent years the annual growth rate of the European general radiography market has stalled to a near standstill. 2018 is expected to see a continuation of the trend, with market revenues forecast to increase by a mere 1%. The market has been buoyed in recent years by the transition from analogue and computed radiography (CR) to fully digital systems, but in Western Europe this trend has largely run its course. However, there are still opportunities for growth, both at a product and country level.

SIIM 2018 saw the attendance of Imaging IT leaders from around the world and Signify Research was also in National Harbor to see the latest technologies to get a sneak peek into what the future of imaging IT might bring.

Capital investment in companies who are developing machine learning solutions for medical image analysis reached $522 million by the end of the first half of 2018. There was a surge of investment towards the end of 2017, with nine deals completed in Q4 2017 worth a combined $141 million. This has continued into 2018, with deal value reaching $143 million across nine deals in the year-to-date.

Here's the Signify View on what this means for GE and Caradigm

Last week I attended the International Conference on Integrated Care (ICIC18) in the Netherlands, leaving with a sense of anticipation that Europe is on the cusp of a monumental healthcare reform.

For a relatively small vendor in the global imaging IT market, the continued growth of Sectra's Imaging IT business over the last two years may have come as a surprise. Add to that a run of new business deals with high profile customers and the Swedish firm is starting to turn heads at its much bigger rivals.

In the build-up to Signify Research’s North American Population Health Management (PHM) market report publication at the end of May, we take a look at some of the highlights from the Q1 2018 results of the larger publicly traded PHM vendors.

Recent hype about cloud technology has yet to materialise in clinical and diagnostic healthcare IT. For advanced visualisation in medical imaging especially, the public cloud hosted solutions accounted for less than 5% of the total US market in 2017, and in the rest of the world, even less.

Here’s the Signify View on these two announcements.

As AI gains traction in the medical imaging market, and its benefits for clinical diagnosis and more accurate early disease detection are being better understood by healthcare stakeholders, it is no longer a question of will AI be used, but rather how will it be deployed.

It was only last year that Analogic was celebrating 50 years as a significant player in the medical imaging supply chain, supporting the extensive growth of the X-ray, CT and MRI markets globally with innovative engineering and unique products. However, the last decade of its history has seen a tumultuous period for the firm with a now uncertain future under new private investment owners.

As news broke of the first GE Healthcare business unit to be sold, some may have been underwhelmed both by the scale and symbolism of this deal. However, this first announcement does provide some useful indicators for what to expect from the future of GE Healthcare with John Flannery at the helm.